Publications by authors named "John H Beigel"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

108,360

Total Likes

1,424

Extended Reach

1,456,499

Social Features

310
R
Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline

N Engl J Med· November 2020

Videos about Article: user user user 5

8 3 50 299 100 827 24

View All Article and Social Media Activity
E
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.
Sharon E Frey, Lindsey R Baden, Hana M El Sahly, Richard T Davey, Paulina A Rebolledo, John H Beigel

Vaccine· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Robert L Atmar, Kirsten E Lyke, Christine M Posavad, Meagan E Deming, Rebecca C Brady, John H Beigel

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.
David J Diemert, Daniel S Graciaa, Bo Zhang, Nadine G Rouphael, Angela R Branche, John H Beigel

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza.
John H Beigel, David Oldach

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus.
Surender Khurana, Lisa R King, Jody Manischewitz, Olivia Posadas, Ashish K Mishra, John H Beigel

Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Nadine G Rouphael, Angela R Branche, David J Diemert, Ann R Falsey, Cecilia Losada, John H Beigel

J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Angela R Branche, Nadine G Rouphael, David J Diemert, Ann R Falsey, Cecilia Losada, John H Beigel

Nat Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, John H Beigel

Clin Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.
Hillary A Vanderven, Deborah N Wentworth, Win Min Han, Heidi Peck, Ian G Barr, John H Beigel

JCI Insight· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
Kirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, Christine M Posavad, Meagan E Deming, John H Beigel

NPJ Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Nadine G Rouphael, Angela R Branche, David J Diemert, Ann R Falsey, Cecilia Losada, John H Beigel

medRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections.
Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, John H Beigel, Tatiana Beresnev

Open Forum Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited.
Sharon E Frey, Johannes B Goll, John H Beigel

N Engl J Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, John H Beigel

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi, John H Beigel

Lancet Respir Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Kirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, Christine M Posavad, Daniel Szydlo, John H Beigel

Cell Rep Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.
Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, Vincent C Marconi, Corri B Levine, John H Beigel

Open Forum Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Clinical Presentations of Human Rhinovirus Species Infection in Children and Adults in Mexico.
Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana M Ortega-Villa, Allyson Mateja, Jesus Arturo Ruiz Quiñones, John H Beigel

Open Forum Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
Angela R Branche, Nadine G Rouphael, David J Diemert, Ann R Falsey, Cecilia Losada, John H Beigel

medRxiv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous and Heterologous Covid-19 Booster Vaccinations.
Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche, John H Beigel

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
Rolando Pajon, Nicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, Sijy O'Dell, John H Beigel

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Andre C Kalil, Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, John H Beigel

Lancet Respir Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report.
Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche, John H Beigel

medRxiv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
Amarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, Sijy O'Dell, Chloe A Talana, John H Beigel, John H Beigel

Science· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016-2018): an observational, prospective cohort study.
Pablo F Belaunzarán-Zamudio, Héctor Armando Rincón León, Sandra Caballero Sosa, Emilia Ruiz, José Gabriel Nájera Cancino, John H Beigel

BMC Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis